Programmatic and clinical management of drug resistant tuberculosis in order to achieve sustainable development goals


Course content

  • Epidemiology of TB, MDR-TB, XDR-TB and TB/HIV; social determinants, migrants and other vulnerable groups
  • WHO’s End TB Strategy and roadmap to implement TB action plan for the European Region, 2016-2020
  • Perspectives of the NTP`s on implementing innovative diagnostics and treatment for MDR-TB 
  • Updates on diagnosis of TB and TB drug resistance; TB diagnostic algorithm proposed by the European TB Laboratory Initiative (ELI)
  • Designing an effective regimen using clinical case scenarios from the field
  • Updates on treatment of drug-susceptible TB and patient care
  • Active drug safety monitoring and management (aDSM)
  • Use of shorter MDR-TB regimens in European regions
  • Treatment of MDR-TB in special situations, TB/HIV co-infection
  • Adjuvant therapies in M/XDR-TB management
  • Fundamentals of infection control; FAST: a TB infection control strategy
  • Management of failures and chronic patients 
  • Developing models of care for MDR-TB patients; people-centered TB care
  • Monitoring of treatment effectiveness and outcome evaluation for TB and MDR-TB patients
  • Procurement and supply management (PSM)

Site visits to MDR-TB department, National TB Reference Laboratory and TB Outpatient department 

REGISTRATION AND INFORMATION

Duration and language:

9 business days (from Monday to Wednesday, including Saturday)

Available in Russian and English

Target audience:  clinicians, staff of national TB programs, persons responsible for diagnostics and treatment of DR-TB, from countries with high levels of DR-TB

Training fee:

1700 EUR, including training materials, site visit, local transport, catering during working hours/on working days, visa support

Additional costs:

hotel accommodation (from ~ 40 EUR to ~ 80 EUR per night), international flight, visa, reduced per diem


 .